US Stock MarketDetailed Quotes

Collegium Pharmaceutical (COLL)

Watchlist
  • 35.620
  • -0.990-2.70%
Close Mar 11 15:59 ET
  • 35.570
  • -0.050-0.14%
Post 20:01 ET
1.13BMarket Cap20.59P/E (TTM)

Collegium Pharmaceutical (COLL) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/FY
Stock NameRevenueRatio
BELBUCA221.65M28.40%
Xtampza Extended-release (ER)199.31M25.53%
Jornay PM148.86M19.07%
Nucynta Immediate-release (IR)115.31M14.77%
Nucynta Extended-release (ER)80.99M10.38%
Symproic14.45M1.85%
View all

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States780.57M100.00%
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the ongoing conflict between the US and Iran has continued to unsettle the stock market. On March 11 local time, Trump once again Show More